NHS emergency departments cannot return to having patients waiting in corridors as the service recovers from the covid-19 […]
Ilaris works by blocking the effects of IL-1 and suppressing inflammation in patients with this autoinflammatory disorder
The company is participating in LifeArc’s funding initiative for COVID-19 clinical trials
The drug will be funded on the NHS to treat ulcerative colitis under certain conditions
The deal gives GSK access to IDEAYA’s MAT2A, Pol Theta, and Werner Helicase programmes
The move follows data from the RECOVERY trial showing no beneficial effect of the drug in patients hospitalised […]
Novartis takes aim at Eli Lilly with Cosentyx FDA nod in spondyloarthritis kblankenship Tue, 06/16/2020 – 21:47
Updated Date: Tue, 09 Jun 2020 00:00:00 EDT
Updated Date: Tue, 09 Jun 2020 00:00:00 EDT
Updated Date: Tue, 09 Jun 2020 00:00:00 EDT